Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Magnesium Sulfate for Emergence Agitation in Pediatric Hypospadias Repair
NCT06306040Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2024
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of nalbuphine, magnesium sulfate in emergence delirium (ED), sponsored by Assiut University. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
nalbuphinemagnesium sulfate
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT06306040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306040.